TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel29-02-2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management PersonnelTORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share CertificatesTORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015Torrent Pharma Q3 Results Review - Strong Performance Across Branded Markets: Nirmal Bang
Domestic revenue grew by 12% YoY to Rs 14.15 billion.Torrent Pharma Q3 Results Review - India, Latin America Drive Earnings: Motilal Oswal
Profitability remains on uptrendTorrent Pharmaceuticals Q3 FY24 Results Live: Profit Rises by 56.54% YoY
Revenue increased by 9.67% YoY & profit increased by 56.54% YoYTORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors Meets under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015